SCN2B and neoplasm: As shown in Figure 9B, among the potential transcripts, high levels of SCN2B in tumor tissues predict poor survival in patients with BLCA (p = 0.0073, log-rank test), suggesting that m1A-regulated mRNAs may be used as biomarkers in BLCA survival prediction.